Harm reduction journal

Keyphrases

Publications

volume 21, number 1, 2024

Kyle J Moon, Heather D Whitehead, Anne Trinh, Kathryn A Hasenstab, Kathleen L Hayes, Debra Stanley, Brittany Carter, Rick Barclay, Marya Lieberman, Saira Nawaz
Enhancing drug checking services for supply monitoring: perspectives on implementation in syringe service programs in the USA. Harm reduction journal 21 (1) (2024)
Cynthia Semá Baltazar, Auria Ribeiro Banze, Jessica Seleme, Makini Boothe
People Who Inject Drugs in Mozambique: We need to normalize HIV treatment and care services in specialized community centers for people who inject drugs! Harm reduction journal 21 (1) (2024)
Raminta Stuikyte, Ivan Varentsov, Catherine Cook, Sergii Dvoriak
Measuring sustainability of opioid agonist therapy programs in the context of transition from global fund support. Harm reduction journal 21 (1) (2024)
Eric Janssen, Mike Vuolo, Stanislas Spilka, Guillaume Airagnes
Predictors of concurrent heroin use among patients on opioid maintenance treatment in France: a multilevel study over 11 years. Harm reduction journal 21 (1) (2024)
Lauren Airth, Trevor Goodyear
Comment on Rose et al.: the need for responsible collection and reporting of demographic data in drug checking research. Harm reduction journal 21 (1) (2024)
Larissa Steimle, Simon Fleißner, Hans Haltmayer, Thilo Beck, Alfred Springer, Heino Stöver
First German-speaking harm reduction conference in Vienna. Harm reduction journal 21 (1) (2024)
Kyle J Moon, Heather D Whitehead, Anne Trinh, Kathryn A Hasenstab, Kathleen L Hayes, Debra Stanley, Brittany Carter, Rick Barclay, Marya Lieberman, Saira Nawaz
Enhancing drug checking services for supply monitoring: perspectives on implementation in syringe service programs in the USA. Harm reduction journal 21 (1) (2024)
Elena Cama, Mitch Beadman, Kim Beadman, Max Hopwood, Carla Treloar
Correction: Health workers' perspectives of hepatitis B-related stigma among Aboriginal and Torres Strait Islander people in New South Wales, Australia. Harm reduction journal 21 (1) (2024)
Layla Maree Edwards, Sungwon Chang, Reem Zeki, Sacha Kendall Jamieson, Julia Bowman, Craig Cooper, Elizabeth Sullivan
The associations between social determinants of health, mental health, substance-use and recidivism: a ten-year retrospective cohort analysis of women who completed the connections programme in Australia. Harm reduction journal 21 (1) (2024)
Heather A Pines, William H Eger, Britt Skaathun, Carlos F Vera, Alicia Harvey-Vera, Gudelia Rangel, Steffanie A Strathdee, Angela R Bazzi
Willingness to use and distribute HIV self-testing kits among people who inject drugs in the San Diego-Tijuana border region. Harm reduction journal 21 (1) (2024)
Angela T Estadt, Brian N White, JaNelle M Ricks, Kathryn E Lancaster, Staci Hepler, William C Miller, David Kline
The impact of fentanyl on state- and county-level psychostimulant and cocaine overdose death rates by race in Ohio from 2010 to 2020: a time series and spatiotemporal analysis. Harm reduction journal 21 (1) (2024)
Lauren Airth, Trevor Goodyear
Comment on Rose et al.: the need for responsible collection and reporting of demographic data in drug checking research. Harm reduction journal 21 (1) (2024)
Laura R Marks, Michael J Durkin, Kelly Ayres, Matthew Ellis
Drug preparation, injection-related infections, and harm reduction practices among a national sample of individuals entering treatment for opioid use disorder. Harm reduction journal 21 (1) (2024)
Angela T Estadt, Brian N White, JaNelle M Ricks, Kathryn E Lancaster, Staci Hepler, William C Miller, David Kline
The impact of fentanyl on state- and county-level psychostimulant and cocaine overdose death rates by race in Ohio from 2010 to 2020: a time series and spatiotemporal analysis. Harm reduction journal 21 (1) (2024)
John C Halifax, Lilly Lim, Daniel Ciccarone, Kara L Lynch
Testing the test strips: laboratory performance of fentanyl test strips. Harm reduction journal 21 (1) (2024)
Sophia Ly, Kate Shannon, Melissa Braschel, Haoxuan Zhou, Andrea Krüsi, Kathleen Deering
Prevalence, correlates, and quality-of-life outcomes of major or persistent pain among women living with HIV in Metro Vancouver, Canada. Harm reduction journal 21 (1) (2024)
Lena van Selm, Trenton M White, Camila A Picchio, Ana Requena-Méndez, Machteld Busz, Roberto Perez Gayo, Aline Pouille, Pedro Mateu Gelabert, Jeffrey V Lazarus
A call to create integrated services to better address the needs of migrants who use drugs in Europe. Harm reduction journal 21 (1) (2024)
Raminta Stuikyte, Ivan Varentsov, Catherine Cook, Sergii Dvoriak
Measuring sustainability of opioid agonist therapy programs in the context of transition from global fund support. Harm reduction journal 21 (1) (2024)
Elena Cama, Mitch Beadman, Kim Beadman, Max Hopwood, Carla Treloar
Correction: Health workers' perspectives of hepatitis B-related stigma among Aboriginal and Torres Strait Islander people in New South Wales, Australia. Harm reduction journal 21 (1) (2024)
Lauren Airth, Trevor Goodyear
Comment on Rose et al.: the need for responsible collection and reporting of demographic data in drug checking research. Harm reduction journal 21 (1) (2024)
Heather Palis, Beth Haywood, Jenny McDougall, Chloé G Xavier, Roshni Desai, Samuel Tobias, Heather Burgess, Max Ferguson, Lisa Liu, Brooke Kinniburgh, Amanda K Slaunwhite, Alexis Crabtree, Jane A Buxton
Factors associated with obtaining prescribed safer supply among people accessing harm reduction services: findings from a cross-sectional survey. Harm reduction journal 21 (1) (2024)
Eloise W Freitag, Yuval Zolotov, Jayabhargav Annam, Jaqueline Labins, Jaclyn M Yamada, Syeda Masharab Jillani, Julia H Arnsten, Deepika E Slawek
Available but inaccessible: patient experiences during the first 2 years of a primary care-based medical cannabis program at an academic medical center. Harm reduction journal 21 (1) (2024)
Cynthia Semá Baltazar, Auria Ribeiro Banze, Jessica Seleme, Makini Boothe
People Who Inject Drugs in Mozambique: We need to normalize HIV treatment and care services in specialized community centers for people who inject drugs! Harm reduction journal 21 (1) (2024)
Eloise W Freitag, Yuval Zolotov, Jayabhargav Annam, Jaqueline Labins, Jaclyn M Yamada, Syeda Masharab Jillani, Julia H Arnsten, Deepika E Slawek
Available but inaccessible: patient experiences during the first 2 years of a primary care-based medical cannabis program at an academic medical center. Harm reduction journal 21 (1) (2024)
Heather A Pines, William H Eger, Britt Skaathun, Carlos F Vera, Alicia Harvey-Vera, Gudelia Rangel, Steffanie A Strathdee, Angela R Bazzi
Willingness to use and distribute HIV self-testing kits among people who inject drugs in the San Diego-Tijuana border region. Harm reduction journal 21 (1) (2024)
John C Halifax, Lilly Lim, Daniel Ciccarone, Kara L Lynch
Testing the test strips: laboratory performance of fentanyl test strips. Harm reduction journal 21 (1) (2024)
Heather A Pines, William H Eger, Britt Skaathun, Carlos F Vera, Alicia Harvey-Vera, Gudelia Rangel, Steffanie A Strathdee, Angela R Bazzi
Willingness to use and distribute HIV self-testing kits among people who inject drugs in the San Diego-Tijuana border region. Harm reduction journal 21 (1) (2024)
Eric Janssen, Mike Vuolo, Stanislas Spilka, Guillaume Airagnes
Predictors of concurrent heroin use among patients on opioid maintenance treatment in France: a multilevel study over 11 years. Harm reduction journal 21 (1) (2024)
Gillian Kolla, Chowdhury Nishwara Tarannum, Kaitlin Fajber, Fiqir Worku, Kris Norris, Cathy Long, Raphaela Fagundes, Anne Rucchetto, Eileen Hannan, Richard Kikot, Michelle Klaiman, Michelle Firestone, Ahmed Bayoumi, Gab Laurence, Kate Hayman
Substance use care innovations during COVID-19: barriers and facilitators to the provision of safer supply at a toronto COVID-19 isolation and recovery site. Harm reduction journal 21 (1) (2024)
Gillian Kolla, Chowdhury Nishwara Tarannum, Kaitlin Fajber, Fiqir Worku, Kris Norris, Cathy Long, Raphaela Fagundes, Anne Rucchetto, Eileen Hannan, Richard Kikot, Michelle Klaiman, Michelle Firestone, Ahmed Bayoumi, Gab Laurence, Kate Hayman
Substance use care innovations during COVID-19: barriers and facilitators to the provision of safer supply at a toronto COVID-19 isolation and recovery site. Harm reduction journal 21 (1) (2024)
Larissa Steimle, Simon Fleißner, Hans Haltmayer, Thilo Beck, Alfred Springer, Heino Stöver
First German-speaking harm reduction conference in Vienna. Harm reduction journal 21 (1) (2024)
Angela T Estadt, Brian N White, JaNelle M Ricks, Kathryn E Lancaster, Staci Hepler, William C Miller, David Kline
The impact of fentanyl on state- and county-level psychostimulant and cocaine overdose death rates by race in Ohio from 2010 to 2020: a time series and spatiotemporal analysis. Harm reduction journal 21 (1) (2024)
Larissa Steimle, Simon Fleißner, Hans Haltmayer, Thilo Beck, Alfred Springer, Heino Stöver
First German-speaking harm reduction conference in Vienna. Harm reduction journal 21 (1) (2024)
Laura R Marks, Michael J Durkin, Kelly Ayres, Matthew Ellis
Drug preparation, injection-related infections, and harm reduction practices among a national sample of individuals entering treatment for opioid use disorder. Harm reduction journal 21 (1) (2024)
Kyle J Moon, Heather D Whitehead, Anne Trinh, Kathryn A Hasenstab, Kathleen L Hayes, Debra Stanley, Brittany Carter, Rick Barclay, Marya Lieberman, Saira Nawaz
Enhancing drug checking services for supply monitoring: perspectives on implementation in syringe service programs in the USA. Harm reduction journal 21 (1) (2024)
Lena van Selm, Trenton M White, Camila A Picchio, Ana Requena-Méndez, Machteld Busz, Roberto Perez Gayo, Aline Pouille, Pedro Mateu Gelabert, Jeffrey V Lazarus
A call to create integrated services to better address the needs of migrants who use drugs in Europe. Harm reduction journal 21 (1) (2024)
Raminta Stuikyte, Ivan Varentsov, Catherine Cook, Sergii Dvoriak
Measuring sustainability of opioid agonist therapy programs in the context of transition from global fund support. Harm reduction journal 21 (1) (2024)
Sophia Ly, Kate Shannon, Melissa Braschel, Haoxuan Zhou, Andrea Krüsi, Kathleen Deering
Prevalence, correlates, and quality-of-life outcomes of major or persistent pain among women living with HIV in Metro Vancouver, Canada. Harm reduction journal 21 (1) (2024)
Lena van Selm, Trenton M White, Camila A Picchio, Ana Requena-Méndez, Machteld Busz, Roberto Perez Gayo, Aline Pouille, Pedro Mateu Gelabert, Jeffrey V Lazarus
A call to create integrated services to better address the needs of migrants who use drugs in Europe. Harm reduction journal 21 (1) (2024)
Sophia Ly, Kate Shannon, Melissa Braschel, Haoxuan Zhou, Andrea Krüsi, Kathleen Deering
Prevalence, correlates, and quality-of-life outcomes of major or persistent pain among women living with HIV in Metro Vancouver, Canada. Harm reduction journal 21 (1) (2024)
Raminta Stuikyte, Ivan Varentsov, Catherine Cook, Sergii Dvoriak
Measuring sustainability of opioid agonist therapy programs in the context of transition from global fund support. Harm reduction journal 21 (1) (2024)
John C Halifax, Lilly Lim, Daniel Ciccarone, Kara L Lynch
Testing the test strips: laboratory performance of fentanyl test strips. Harm reduction journal 21 (1) (2024)
Heather Palis, Beth Haywood, Jenny McDougall, Chloé G Xavier, Roshni Desai, Samuel Tobias, Heather Burgess, Max Ferguson, Lisa Liu, Brooke Kinniburgh, Amanda K Slaunwhite, Alexis Crabtree, Jane A Buxton
Factors associated with obtaining prescribed safer supply among people accessing harm reduction services: findings from a cross-sectional survey. Harm reduction journal 21 (1) (2024)
Cynthia Semá Baltazar, Auria Ribeiro Banze, Jessica Seleme, Makini Boothe
People Who Inject Drugs in Mozambique: We need to normalize HIV treatment and care services in specialized community centers for people who inject drugs! Harm reduction journal 21 (1) (2024)
Laura R Marks, Michael J Durkin, Kelly Ayres, Matthew Ellis
Drug preparation, injection-related infections, and harm reduction practices among a national sample of individuals entering treatment for opioid use disorder. Harm reduction journal 21 (1) (2024)
Eric Janssen, Mike Vuolo, Stanislas Spilka, Guillaume Airagnes
Predictors of concurrent heroin use among patients on opioid maintenance treatment in France: a multilevel study over 11 years. Harm reduction journal 21 (1) (2024)
Heather Palis, Beth Haywood, Jenny McDougall, Chloé G Xavier, Roshni Desai, Samuel Tobias, Heather Burgess, Max Ferguson, Lisa Liu, Brooke Kinniburgh, Amanda K Slaunwhite, Alexis Crabtree, Jane A Buxton
Factors associated with obtaining prescribed safer supply among people accessing harm reduction services: findings from a cross-sectional survey. Harm reduction journal 21 (1) (2024)
Layla Maree Edwards, Sungwon Chang, Reem Zeki, Sacha Kendall Jamieson, Julia Bowman, Craig Cooper, Elizabeth Sullivan
The associations between social determinants of health, mental health, substance-use and recidivism: a ten-year retrospective cohort analysis of women who completed the connections programme in Australia. Harm reduction journal 21 (1) (2024)
Layla Maree Edwards, Sungwon Chang, Reem Zeki, Sacha Kendall Jamieson, Julia Bowman, Craig Cooper, Elizabeth Sullivan
The associations between social determinants of health, mental health, substance-use and recidivism: a ten-year retrospective cohort analysis of women who completed the connections programme in Australia. Harm reduction journal 21 (1) (2024)
Eloise W Freitag, Yuval Zolotov, Jayabhargav Annam, Jaqueline Labins, Jaclyn M Yamada, Syeda Masharab Jillani, Julia H Arnsten, Deepika E Slawek
Available but inaccessible: patient experiences during the first 2 years of a primary care-based medical cannabis program at an academic medical center. Harm reduction journal 21 (1) (2024)